KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Bio-Rad Laboratories (BIO) Receivables - Other (2019 - 2026)

Bio-Rad Laboratories has reported Receivables - Other over the past 8 years, most recently at $13.3 million for Q1 2026.

  • Quarterly Receivables - Other fell 2.92% to $13.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $13.3 million through Mar 2026, down 2.92% year-over-year, with the annual reading at $11.9 million for FY2025, 9.16% down from the prior year.
  • Receivables - Other was $13.3 million for Q1 2026 at Bio-Rad Laboratories, up from $11.9 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $14.8 million in Q1 2023 and troughed at $6.3 million in Q2 2022.
  • The 5-year median for Receivables - Other is $11.2 million (2023), against an average of $10.9 million.
  • Year-over-year, Receivables - Other surged 427.27% in 2022 and then fell 17.35% in 2025.
  • A 5-year view of Receivables - Other shows it stood at $11.6 million in 2022, then rose by 2.59% to $11.9 million in 2023, then rose by 10.08% to $13.1 million in 2024, then dropped by 9.16% to $11.9 million in 2025, then rose by 11.76% to $13.3 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Receivables - Other are $13.3 million (Q1 2026), $11.9 million (Q4 2025), and $9.5 million (Q3 2025).